Smart Peptide Masking System Enables Protein Drug Delivery Inside Cells | Research

The takeaway

Charge-guided masking of a membrane-destabilizing peptide creates a delivery system that efficiently escapes endosomes, enabling intracellular protein delivery for targeted therapy.

Endosomal escape solved
pH-responsive charge masking activates a membrane-disrupting peptide only inside endosomes, releasing trapped protein cargo into the cell

What the researchers found

Charge-guided masking creates a pH-responsive peptide that is inactive at normal pH but unmasks in acidic endosomes to disrupt membranes and release cargo, enabling efficient intracellular protein delivery.

Why it matters

Many potential protein and peptide drugs cannot reach their intracellular targets because they are trapped and destroyed in endosomes. Solving this "endosomal escape" problem could unlock an entire class of previously undevelopable therapies.

The numbers in context

The system activated at endosomal pH (~5), releasing the protein cargo from endosomal entrapment efficiently.

How the study worked

Designed charge-masked membrane-destabilizing peptide. Characterized pH-dependent unmasking and membrane disruption. Tested endosomal escape efficiency and intracellular protein delivery in cell models.

Who was studied

Cell culture studies of pH-responsive endosomal escape peptide system

What this study cannot tell us

Cell culture study — in vivo delivery efficiency, biodistribution, and safety are unknown. The efficiency of endosomal escape may vary across cell types and targets. Scale-up and manufacturing complexity need evaluation.

How to read the evidence

Preliminary evidence: proof-of-concept cell culture study demonstrating a novel delivery mechanism. No in vivo data.

When this study was published

Published in 2024. Addresses the critical endosomal escape bottleneck in drug delivery.

The bigger picture

The endosomal escape problem is considered one of the biggest bottlenecks in biological drug delivery. This elegant charge-masking approach adds to growing toolkit of solutions, alongside cell-penetrating peptides and lipid nanoparticles, that could collectively enable a new generation of intracellular therapies.

Questions still open

How does this system perform in vivo compared to existing endosomal escape strategies?
Can the masking approach be adapted for different cargo sizes and types?
What is the safety profile of membrane-destabilizing peptides in living organisms?

Common questions

What is the endosomal escape problem?

When protein drugs enter cells, they get trapped in endosomes — bubble-like compartments that eventually digest their contents. The drug never reaches its target inside the cell. This charge-masking system uses a peptide that breaks open the endosome only when needed, freeing the drug.

How does the charge masking work?

At normal body pH, the membrane-disrupting peptide is "masked" by opposite charges that keep it inactive. Inside acidic endosomes, the pH change alters these charges, unmasking the peptide so it can punch through the endosome membrane and release the drug cargo.

Read the original research

Charge-guided masking of a membrane-destabilizing peptide enables efficient endosomal escape for targeted intracellular delivery of proteins.

Acta pharmaceutica Sinica. B, 14(10), 4478-4492

View on PubMed ↗Publisher’s paper ↗

Citation

Zhao, Yan; Jiang, Haolin; Chen, Hang; Yu, Jiazhen; Wang, Luyao; Zhou, Wen; Du, Juanjuan. (2024). Charge-guided masking of a membrane-destabilizing peptide enables efficient endosomal escape for targeted intracellular delivery of proteins.. Acta pharmaceutica Sinica. B, 14(10), 4478-4492. https://doi.org/10.1016/j.apsb.2024.06.022